Cargando…
Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy
U.S. SEER (Surveillance Epidemiology and End Results) data for age-adjusted mortality rates for all cancers combined for all races show only a modest overall 13% decline over the past 35 years. Moreover, the greatest contributor to cancer mortality is treatment-resistant metastatic disease. The acce...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691519/ https://www.ncbi.nlm.nih.gov/pubmed/23805101 http://dx.doi.org/10.3389/fphar.2013.00068 |